Age
18 - 50
Check your eligibility now & get in touch with a study center
CHECK ELIGIBILITYLorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus element
You can use content blocks to arrange your articles, large texts, instructions. Combine these blocks with media blocks to add illustrations and video tutorials. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links.
Take up this questionnaire to help us determine if you have symptoms that are common to this clinical study. If you have the common symptoms, you may be eligible to take part in the study.
18 - 50
Both
NCT05101018
4
Recruiting Now
Osteoporosis
A short sentence to introduce what to expect in the about condition section
Learn moreA short sentence to introduce what to expect in the about condition section
Learn moreA short sentence to introduce what to expect in the about condition section
Learn moreYou would receive etanercept (Enbrel) twice a week for 12 weeks and then once a week for 12 weeks. Etanercept, as well as study related medical care, is provided at no cost.
Study participation involves approximately 8 visits to your local study center over 6 to 7 months.
There would also be a follow-up telephone call 30days after completing the study. No visits are required after participation is complete.
Roberta Hills, PhD
Professor at the University of Washington
TrialX is developing novel, proprietary technologies that enable patients to find and learn about clinical trials that match their health conditions and connect with the trial investigators effortlessly using a unique web messaging platform.